Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.
2.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.

Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.

PMID:
29146401
3.

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.

Stemmer SM, Steiner M, Rizel S, Soussan-Gutman L, Ben-Baruch N, Bareket-Samish A, Geffen DB, Nisenbaum B, Isaacs K, Fried G, Rosengarten O, Uziely B, Svedman C, McCullough D, Maddala T, Klang SH, Zidan J, Ryvo L, Kaufman B, Evron E, Karminsky N, Goldberg H, Shak S, Liebermann N.

NPJ Breast Cancer. 2017 Sep 8;3:33. doi: 10.1038/s41523-017-0034-6. eCollection 2017.

4.

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.

Stemmer SM, Steiner M, Rizel S, Geffen DB, Nisenbaum B, Peretz T, Soussan-Gutman L, Bareket-Samish A, Isaacs K, Rosengarten O, Fried G, McCullough D, Svedman C, Shak S, Liebermann N, Ben-Baruch N.

NPJ Breast Cancer. 2017 Sep 8;3:32. doi: 10.1038/s41523-017-0033-7. eCollection 2017.

5.

Impact of a 3-Day Introductory Oncology Course on First-Year International Medical Students.

Granek L, Mizrakli Y, Ariad S, Jotkowitz A, Geffen DB.

J Cancer Educ. 2017 Sep;32(3):640-646. doi: 10.1007/s13187-015-0972-3.

PMID:
26847466
6.

Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission.

Adachi K, Klausner JD, Bristow CC, Xu J, Ank B, Morgado MG, Watts DH, Weir F, Persing D, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Nielsen-Saines K; NICHD HPTN 040 Study Team.

Sex Transm Dis. 2015 Oct;42(10):554-65. doi: 10.1097/OLQ.0000000000000340.

7.

Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysis.

Fraenkel M, Geffen DB, Novack V, Shafat T, Mizrakli Y, Ariad S, Koretz M, Norton L, Siris E.

NPJ Breast Cancer. 2015 Jul 22;1:15010. doi: 10.1038/npjbcancer.2015.10. eCollection 2015.

8.

Emergency department revisits for patients with kidney stones in California.

Scales CD Jr, Lin L, Saigal CS, Bennett CJ, Ponce NA, Mangione CM, Litwin MS; NIDDK Urologic Diseases in America Project.

Acad Emerg Med. 2015 Apr;22(4):468-74. doi: 10.1111/acem.12632. Epub 2015 Mar 16.

9.

The preoperative neutrophil/lymphocyte ratio does not correlate with the 21-gene recurrence score in estrogen receptor-positive breast cancer patients.

Grenader T, Plotkin Y, Geffen DB.

Oncol Res Treat. 2015;38(1-2):24-7. doi: 10.1159/000370341. Epub 2015 Jan 12.

PMID:
25634254
10.

Early exposure to a clinical oncology course during the preclinical second year of medical school.

Granek L, Lazarev I, Birenstock-Cohen S, Geffen DB, Riesenberg K, Ariad S.

Acad Med. 2015 Apr;90(4):454-7. doi: 10.1097/ACM.0000000000000521.

PMID:
25319175
11.
12.

The 21-gene recurrence score assay (Oncotype DX™) in estrogen receptor-positive male breast cancer: experience in an Israeli cohort.

Grenader T, Yerushalmi R, Tokar M, Fried G, Kaufman B, Peretz T, Geffen DB.

Oncology. 2014;87(1):1-6. doi: 10.1159/000360793. Epub 2014 Jun 20.

PMID:
24970679
13.

Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.

Lazarev I, Leibovitch L, Czeiger D, Sion-Vardi N, Geffen DB, Douvdevani A, Ariad S.

In Vivo. 2014 May-Jun;28(3):349-54.

PMID:
24815837
14.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

15.

Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update.

American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus, Moreno G, Mangione CM, Kimbro L, Vaisberg E.

J Am Geriatr Soc. 2013 Nov;61(11):2020-6. doi: 10.1111/jgs.12514. No abstract available.

16.

Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a 'switching' policy in postmenopausal patients after initial tamoxifen.

Geffen DB, Tokar M, Abu-Ghanem S, Braunstein R, Koretz M, Amir N, Delgado B, Sion-Vardi N, Ariad S, Lazarev I.

Oncology. 2013;85(3):145-52. doi: 10.1159/000353978. Epub 2013 Aug 28.

PMID:
23988814
17.

Association between bone mineral density and incidence of breast cancer.

Fraenkel M, Novack V, Liel Y, Koretz M, Siris E, Norton L, Shafat T, Shany S, Geffen DB.

PLoS One. 2013 Aug 5;8(8):e70980. doi: 10.1371/journal.pone.0070980. Print 2013. Erratum in: PLoS One. 2013;8(9). doi: 10.1371/annotation/2811f3e3-8efe-4183-bcd7-e4a11401fb89.

18.

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.

Stemmer SM, Klang SH, Ben-Baruch N, Geffen DB, Steiner M, Soussan-Gutman L, Merling S, Svedman C, Rizel S, Lieberman N.

Breast Cancer Res Treat. 2013 Jul;140(1):83-92. doi: 10.1007/s10549-013-2603-1. Epub 2013 Jun 26.

19.

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine.

Geva S, Lazarev I, Geffen DB, Ariad S.

J Chemother. 2013 Jun;25(3):176-80. doi: 10.1179/1973947813Y.0000000072.

PMID:
23783143
20.

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*.

Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

PMID:
23648946

Supplemental Content

Loading ...
Support Center